US 10980872
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 10980872 (Genetically stable live attenuated respiratory syncytial virus vaccine and its production) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/5254, A61K39/12, A61K39/155